DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactResults

Sumitomo Chemical India: Investor Presentation for Q2 & H1 FY27 Financial Results

InvestyWise 1 hr ago·26 Oct 2026, 5:36 pm

Sumitomo Chemical India held an investor presentation covering its second‑quarter and first‑half FY27 results, outlining revenue trends, margin performance and key operational highlights.

For investors, the briefing offers a direct view of how the domestic chemicals business is navigating price volatility and shifting demand, and it may hint at any revisions to the company’s guidance.

Going forward, keep an eye on updates about new product launches, capacity expansions and the outlook for the rest of FY27, as well as the impact of raw‑material cost trends on earnings.